BRPI0312377A8 - Suspensão aquosa estéril contendo ciclesonida - Google Patents

Suspensão aquosa estéril contendo ciclesonida

Info

Publication number
BRPI0312377A8
BRPI0312377A8 BRPI0312377A BR0312377A BRPI0312377A8 BR PI0312377 A8 BRPI0312377 A8 BR PI0312377A8 BR PI0312377 A BRPI0312377 A BR PI0312377A BR 0312377 A BR0312377 A BR 0312377A BR PI0312377 A8 BRPI0312377 A8 BR PI0312377A8
Authority
BR
Brazil
Prior art keywords
aqueous suspension
suspension containing
sterile aqueous
cyclesonide
autoclaving
Prior art date
Application number
BRPI0312377A
Other languages
English (en)
Other versions
BR0312377A (pt
Inventor
Nishibe Yoshihisa
Nagano Atsuhiro
Takanashi Kazuya
Uejima Yasuhide
Original Assignee
Altana Pharma Ag
Nycomed Gmbh
Takeda Gmbh
Nycomed Asset Man Gmbh
Nycomed Germany Holding Gmbh
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag, Nycomed Gmbh, Takeda Gmbh, Nycomed Asset Man Gmbh, Nycomed Germany Holding Gmbh, Astrazeneca Ab filed Critical Altana Pharma Ag
Publication of BR0312377A publication Critical patent/BR0312377A/pt
Publication of BRPI0312377A8 publication Critical patent/BRPI0312377A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SUSPENSÃO AQUOSA ESTÉRIL CONTENDO CICLESONIDA. A presente invenção refere-se a uma suspensão aquosa estéril contendo ciclesonida através de autoclave, onde a concentração de ciclesonida após autoclave é 95% ou mais comparando com aquela antes da auto-clave. A presente invenção provê também um método de fabricação de uma suspensão aquosa estéril contendo ciclesonida compreendendo a etapa de esterilização através de autoclave de uma suspensão aquosa contendo ciclesonida.
BRPI0312377A 2002-07-02 2003-07-02 Suspensão aquosa estéril contendo ciclesonida BRPI0312377A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002193399 2002-07-02
PCT/JP2003/008410 WO2004004739A1 (en) 2002-07-02 2003-07-02 Ciclesonide-containing sterile aqueous suspension

Publications (2)

Publication Number Publication Date
BR0312377A BR0312377A (pt) 2005-04-12
BRPI0312377A8 true BRPI0312377A8 (pt) 2015-12-15

Family

ID=30112281

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0312377A BRPI0312377A8 (pt) 2002-07-02 2003-07-02 Suspensão aquosa estéril contendo ciclesonida

Country Status (18)

Country Link
US (2) US8182824B2 (pt)
EP (2) EP1519734A4 (pt)
JP (1) JP4559221B2 (pt)
KR (1) KR101020687B1 (pt)
CN (1) CN100366256C (pt)
AU (1) AU2003245043B2 (pt)
BR (1) BRPI0312377A8 (pt)
CA (1) CA2491724C (pt)
EA (1) EA009843B1 (pt)
HK (1) HK1080365B (pt)
HR (1) HRP20050062B1 (pt)
IL (1) IL165666A (pt)
MX (1) MXPA04012756A (pt)
NO (1) NO335022B1 (pt)
NZ (1) NZ537945A (pt)
PL (1) PL224989B1 (pt)
RS (1) RS57455B1 (pt)
WO (1) WO2004004739A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4364486B2 (ja) * 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
ATE405275T1 (de) * 2002-12-12 2008-09-15 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
WO2011135585A2 (en) * 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
WO2022231532A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288679A (en) 1966-03-23 1966-11-29 Squibb & Sons Inc Steroidal compositions and method of use
US3692430A (en) * 1971-06-18 1972-09-19 John W Timmons Liquid pumping system
US3962430A (en) 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
SE8600632D0 (sv) * 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6066292A (en) * 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
JP2001048807A (ja) * 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
AU7947600A (en) * 1999-10-20 2001-04-30 Teijin Limited Aqueous medicinal compositions
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
EP1337279B1 (en) 2000-11-24 2006-06-21 Breath Limited Sterilisation of glucocorticosteriode suspensions
JP4364486B2 (ja) 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
CA2525943A1 (en) * 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination

Also Published As

Publication number Publication date
EA009843B1 (ru) 2008-04-28
WO2004004739A1 (en) 2004-01-15
US20100034696A1 (en) 2010-02-11
KR101020687B1 (ko) 2011-03-11
EA200500123A1 (ru) 2005-08-25
PL224989B1 (pl) 2017-02-28
HK1080365B (zh) 2008-11-28
EP1519734A1 (en) 2005-04-06
RS57455B1 (sr) 2018-09-28
BR0312377A (pt) 2005-04-12
JP4559221B2 (ja) 2010-10-06
IL165666A0 (en) 2006-01-15
CN1665517A (zh) 2005-09-07
CA2491724C (en) 2013-04-02
CN100366256C (zh) 2008-02-06
RS113404A (sr) 2007-02-05
US20060166953A1 (en) 2006-07-27
EP3513813A1 (en) 2019-07-24
CA2491724A1 (en) 2004-01-15
AU2003245043B2 (en) 2009-01-29
MXPA04012756A (es) 2005-03-23
NO335022B1 (no) 2014-08-25
NO20050529L (no) 2005-02-01
US8268240B2 (en) 2012-09-18
HRP20050062B1 (hr) 2013-11-08
JP2005535656A (ja) 2005-11-24
EP1519734A4 (en) 2011-02-23
US8182824B2 (en) 2012-05-22
NZ537945A (en) 2007-08-31
PL372940A1 (en) 2005-08-08
HK1080365A1 (en) 2006-04-28
HRP20050062A2 (hr) 2006-04-30
KR20050016706A (ko) 2005-02-21
AU2003245043A1 (en) 2004-01-23
IL165666A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
HRP20050062B1 (hr) Sterilna vodena suspenzija koja sadržava ciklesonid
CY1117681T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
ATE534730T1 (de) Diagnose und behandlung von multiplen sulfatase- erkrankungen und anderen mit hilfe eines formylglycin bildenden enzyms
NO20045589L (no) Nye forbindelser
BR0312729A (pt) Novos derivados de indol-3-enxofre
NO20050063L (no) 2-heteroaryl karboksamider
UY28186A1 (es) N-arilheterociclos sustituidos, procedimientos para su preparación, y su empleo como medicamentos.
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
MA49628B1 (fr) Processus pour la purification de l'acide hyaluronique
BRPI0511874A (pt) derivados da pirrolopiridina
BRPI0517846A (pt) azaindolcarboxamidas
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
MA27670A1 (fr) Composition pharmaceutique contenant de l'acide 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetique
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
NO20060718L (no) Substituerte tiofoner og deres anvendelse
BRPI0407055A (pt) Derivados de isotiazol
MA28340A1 (fr) Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments
NO20076405L (no) Anvendelse av 24-nor-UDCA
DK1656360T3 (da) Thiazolinderivater som selektive androgenreceptor-modulatorer
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.
ATE369849T1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
NO20060229L (no) Gaboxadol for behandling av depresjon og andre affektive lidelser
DE602006021594D1 (de) Verbindung zur prävention und behandlung von links

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG.

B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/58, 47/38, 9/107; A61P 29/00

Ipc: A61K 31/58 (2011.01), A61K 47/38 (2011.01), A61K 9

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11, 16 E 25 DA LPI.

B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)